相关实验视频
Updated: Jun 4, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
通过实施处方者向决策支持工具来降低住院患者的低血糖率
Jessica Odom1, Rebecca Goldstein2
1Prisma Health, Pharmacy, 701 Grove Road, Greenville, SC, 29605, USA. Jessica.Odom@prismahealth.org.
Current diabetes reports
|January 4, 2025
概括
临床决策支持 (CDS) 工具可以帮助减少医院低血糖. 虽然对高血糖有效,但它们对预防低血糖的影响有所不同,因此需要进一步研究先进的工具.
科学领域:
- 临床信息学 临床信息学
- 内分泌学 在内分泌学.
- 患者安全 患者安全
背景情况:
- 低血糖会增加死亡率和住院时间,是CMS的质量衡量标准.
- 有效的住院血糖控制对于患者的治疗结果至关重要.
研究的目的:
- 审查临床决策支持 (CDS) 工具,以减少住院患者的低血糖.
- 确定改善住院患者血糖表现的策略.
主要方法:
- 审查现有的关于CDS工具的文献,用于血糖管理.
- 分析各种CDS干预措施 (订单集,警报,数据可见性) 的有效性.
主要成果:
- 订单集和警报等CDS工具可以提高血糖表现,特别是在高血糖的情况下.
- 使用CDS预防低血糖已经显示出混合的结果.
- 针对医疗保健专业人员或糖尿病团队的有针对性的CDS可以减少低血糖.
- 不间断的警报对于识别有风险的患者是有价值的,特别是当专门的团队是不可行的.
结论:
- 在住院患者中,CDS提供了一种可行的机制,以减轻低血糖风险.
- 需要对持续的葡萄糖监测和预测模型进行进一步的研究,以加强血糖控制.
相关概念视频
Hypoglycemia and Glucagon
150
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
150
Dipeptidyl Peptidase 4 Inhibitors
166
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
166
Oral Hypoglycemic Agents: Biguanides and Glitazones
165
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
165
Oral Hypoglycemic Agents: Glinides
136
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
136
SBAR II: Application of SBAR
4.3K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.3K
Diabetes: Management and Pharmacotherapy
233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233

